
|
Effect of calcineurin inhibitors on myotoxic activity of crotoxin and Bothrops asper phospholipase A"2 myotoxins in vivo and in vitro [An article from: Comparative Biochemistry and Physiology, Part C]
by E.H. Miyabara (Author), I.L. Baptista (Author), B. Lomonte (Author), Selistre (Author)
This digital document is a journal article from Comparative Biochemistry and Physiology, Part C, published by Elsevier in 2006. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.
Description: Previous studies have shown that calcineurin activity plays a critical role in the myotoxic activity induced by crotoxin (CTX), a group II phospholipase A"2 (PLA"2) with neurotoxic and myotoxic actions. In order to address whether calcineurin is also important for the activity of non-neurotoxic group II PLA"2 myotoxins we have compared the effects of calcineurin inhibition on the myotoxic capacity of CTX and the non-neurotoxic PLA"2s, myotoxin II (Mt II) and myotoxin III (Mt III) from...
|

|
Calcium Homeostasis
by Springer
This new "Topics" series is an "offspring" of our well established series "Structure and Bonding". The foundation of TBIC reflects the importance research has gained at the interface of inorganic and biological chemistry in the past years. Biological inorganic chemistry is a field of research at the interface of inorganic and biological chemistry. The rapidly developing insights into the role of metals in biological systems has far-reaching implications not only for biological science but also for related disciplines, ranging from molecular medicine to the environment. In each volume the reader, whether engaged in chemistry, biochemistry, biology or molecular medicine, receives a comprehensive summary and critical overview of a topic of high current interest written by leading...
|
|
|
Calcineurin inhibitors offer advantages for eczema: tacrolimus, pimecrolimus.(Children's Health): An article from: Family Practice News
by Kate Johnson (Author)
This digital document is an article from Family Practice News, published by International Medical News Group on January 1, 2004. The length of the article is 862 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Calcineurin inhibitors offer advantages for eczema: tacrolimus, pimecrolimus.(Children's Health) Author: Kate Johnson Publication: Family Practice News (Magazine/Journal) Date: January 1, 2004 Publisher: International Medical News Group Volume: 34 Issue: 1 Page: 69(1)
Distributed by Thomson...
|
|
|
Early data suggest calcineurin inhibitors are safe for infants: atopic dermatitis therapy.(Dermatologic Therapy)(pimecrolimus cream): An article from: Skin & Allergy News
by Sherry Boschert (Author)
This digital document is an article from Skin & Allergy News, published by International Medical News Group on February 1, 2004. The length of the article is 1157 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Early data suggest calcineurin inhibitors are safe for infants: atopic dermatitis therapy.(Dermatologic Therapy)(pimecrolimus cream) Author: Sherry Boschert Publication: Skin & Allergy News (Magazine/Journal) Date: February 1, 2004 Publisher: International Medical News Group Volume: 35 Issue: 2 Page: 28(1)
Distributed by Thomson...
|
|
|
Topical calcineurin inhibitors can still be used in children.(Skin Disorders): An article from: Family Practice News
by Robert Finn (Author)
This digital document is an article from Family Practice News, published by Thomson Gale on October 15, 2005. The length of the article is 496 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Topical calcineurin inhibitors can still be used in children.(Skin Disorders) Author: Robert Finn Publication: Family Practice News (Magazine/Journal) Date: October 15, 2005 Publisher: Thomson Gale Volume: 35 Issue: 20 Page: 35(1)
Distributed by Thomson...
|
|
|
Treating kids? Use topical calcineurin inhibitor with topical corticosteroid: for itching and burning.(Dermatologic Theraphy): An article from: Skin & Allergy News
by Robert Finn (Author)
This digital document is an article from Skin & Allergy News, published by International Medical News Group on August 1, 2003. The length of the article is 2581 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Treating kids? Use topical calcineurin inhibitor with topical corticosteroid: for itching and burning.(Dermatologic Theraphy) Author: Robert Finn Publication: Skin & Allergy News (Magazine/Journal) Date: August 1, 2003 Publisher: International Medical News Group Volume: 34 Issue: 8 Page: 24(1)
Distributed by Thomson...
|
|
|
Calcineurin inhibitors may pose cancer risk in children: box warning needed.(Children's Health): An article from: Family Practice News
by Sally Koch Kubetin (Author)
This digital document is an article from Family Practice News, published by International Medical News Group on March 1, 2004. The length of the article is 894 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Calcineurin inhibitors may pose cancer risk in children: box warning needed.(Children's Health) Author: Sally Koch Kubetin Publication: Family Practice News (Magazine/Journal) Date: March 1, 2004 Publisher: International Medical News Group Volume: 34 Issue: 5 Page: 112(1)
Distributed by Thomson...
|
|
|
Primary care cuts use of calcineurin inhibitors.(Skin Disorders)(treatments used by pediatric dermatologists evaluated): An article from: Family Practice News
by Bruce Jancin (Author)
This digital document is an article from Family Practice News, published by Thomson Gale on May 1, 2006. The length of the article is 986 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Primary care cuts use of calcineurin inhibitors.(Skin Disorders)(treatments used by pediatric dermatologists evaluated) Author: Bruce Jancin Publication: Family Practice News (Magazine/Journal) Date: May 1, 2006 Publisher: Thomson Gale Volume: 36 Issue: 9 Page: 27(1)
Distributed by Thomson...
|
|
|
Panel assesses calcineurin inhibitors in children: FDA advisory panel.(Dermatologic Therapy): An article from: Skin & Allergy News
by Sally Koch Kubetin (Author)
This digital document is an article from Skin & Allergy News, published by International Medical News Group on December 1, 2003. The length of the article is 728 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Panel assesses calcineurin inhibitors in children: FDA advisory panel.(Dermatologic Therapy) Author: Sally Koch Kubetin Publication: Skin & Allergy News (Magazine/Journal) Date: December 1, 2003 Publisher: International Medical News Group Volume: 34 Issue: 12 Page: 18(1)
Distributed by Thomson...
|
|
|
Box warning needed to correct calcineurin inhibitors misuse: FDA panel advisory.(Clinical Rounds): An article from: Pediatric News
b
This digital document is an article from Pediatric News, published by International Medical News Group on December 1, 2003. The length of the article is 562 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Box warning needed to correct calcineurin inhibitors misuse: FDA panel advisory.(Clinical Rounds) Publication: Pediatric News (Magazine/Journal) Date: December 1, 2003 Publisher: International Medical News Group Volume: 37 Issue: 12 Page: 29(1)
Distributed by Thomson...
|